Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy



Status:Recruiting
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - Any
Updated:3/30/2019
Start Date:October 15, 2018
End Date:January 2022

Use our guide to learn which trials are right for you!

A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study)

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025
in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of
systemic therapy

Phase 2, open label, randomized, multicenter study in subjects with cGVHD who have previously
been treated with at least 2 prior lines of systemic therapy. Approximately 126 subjects with
active cGVHD will be randomized (1:1) to receive treatment with one of two KD025 regimens:

- Arm A: KD025 200mg QD

- Arm B: KD025 200mg BID

Randomization will be stratified according to prior cGVHD treatment with ibrutinib (Yes / No)
and severe cGVHD at baseline (Yes / No). Subjects may receive treatment in 28-day treatment
cycles until progression of cGVHD. Subjects who have not achieved a response after 12 cycles
of KD025 should be withdrawn if in the Investigator's judgment there is no evidence of
clinical benefit. Subjects will undergo evaluations as outlined in the Study Assessments
table. The primary endpoint is the overall response rate (ORR) with responses as defined by
the 2014 National Institute of Health (NIH) Consensus Development Project on clinical trials
in cGVHD.

Inclusion Criteria:

1. Adult male and female subjects at least 18 years of age who have had allogenic
hematopoietic cell transplant (HCT).

2. Previously received at least 2 and not more than 5 lines of systemic therapy for cGVHD

3. Receiving glucocorticoid therapy with a stable dose over the 2 weeks prior to
screening

4. Have persistent cGVHD manifestations and systemic therapy is indicated

5. Karnofsky Performance Score of ≥ 60

Exclusion Criteria:

1. Received a systemic investigational cGVHD treatment within 28 days of study entry.
Prior treatment is allowed with a washout of at least 5 half-lives or 28 days. (Note:
Corticosteroids, calcineurin inhibitors, sirolimus, MMF, methotrexate and ECP are
acceptable and subjects must have been on a stable dose / regimen of these for at
least 2 weeks prior to screening).

2. Histological relapse of the underlying cancer or post-transplant lymphoproliferative
disease at the time of screening.

3. Current treatment with ibrutinib. Prior treatment with ibrutinib is allowed with a
washout of at least 28 days prior to randomization.
We found this trial at
24
sites
Milwaukee, Wisconsin
Phone: 414-805-8755
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
1648 Pierce Dr NE
Atlanta, Georgia 30322
(404) 727-5640
Phone: 404-778-4236
Emory University School of Medicine Emory University School of Medicine has 2,359 full- and part-time...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Phone: 617-724-1124
?
mi
from
Boston, MA
Click here to add this to my saved trials
4100 John R
Detroit, Michigan 48201
800-527-6266
Phone: 313-576-9271
Barbara Ann Karmanos Cancer Institute Karmanos is based in southeast Michigan, in midtown Detroit, and...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
101 Jessup Hall
Iowa City, Iowa 52242
(319) 335-3500
Phone: 319-356-8133
University of Iowa With just over 30,000 students, the University of Iowa is one of...
?
mi
from
Iowa City, IA
Click here to add this to my saved trials
Los Angeles, California 90095
310-825-4321
Phone: 310-794-0242
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Minneapolis, Minnesota 55455
(612) 625-5000
Phone: 612-624-0123
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Phone: 615-936-8422
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Phone: 585-275-5345
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
12902 USF Magnolia Dr
Tampa, Florida 33612
(888) 663-3488
Phone: 813-745-3774
H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer Center in Tampa, Florida, has...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Augusta, Georgia 30912
Phone: 706-721-2505
?
mi
from
Augusta, GA
Click here to add this to my saved trials
901 West Ben White Boulevard
Austin, Texas 78704
Phone: 512-816-8682
?
mi
from
Austin, TX
Click here to add this to my saved trials
450 Brookline Ave
Boston, Massachusetts 2215
617-632-3000
Phone: 617-632-3470
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
?
mi
from
Boston, MA
Click here to add this to my saved trials
1721 East 19th Ave., Suite #200 & #300
Denver, Colorado 80218
720-754-4800
Colorado Blood Cancer Institute When patients come to the Colorado Blood Cancer Institute, the entire...
?
mi
from
Denver, CO
Click here to add this to my saved trials
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
Phone: 626-256-4673
City of Hope National Medical Center City of Hope is dedicated to making a difference...
?
mi
from
Duarte, CA
Click here to add this to my saved trials
Fairway, Kansas 66205
Phone: 913-945-7552
?
mi
from
Fairway, KS
Click here to add this to my saved trials
1515 Holcombe Blvd
Houston, Texas 77030
 713-792-2121
Phone: 713-792-2808
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Nashville, Tennessee 37203
Phone: 615-342-4914
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Portland, Oregon 97239
Phone: 503-494-5058
?
mi
from
Portland, OR
Click here to add this to my saved trials
Saint Louis, Missouri
Phone: 314-273-2747
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Antonio, Texas 78229
Phone: 210-575-4238
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Seattle, Washington 98103
Phone: 206-667-6190
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Stanford, California 94305
Phone: 650-721-4183
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Tucson, Arizona 85724
Phone: 520-626-0301
?
mi
from
Tucson, AZ
Click here to add this to my saved trials